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ABSTRACT Molecular interaction of a self-assembling peptide, EAK16-II, to single- and double-stranded oligodeoxynucleotides
(ODNs) was investigated under various solution conditions. The molecular events leading to EAK-ODN complexation and further
aggregation were elucidated using a series of spectroscopic and microscopic methods. Despite the ability to self-assemble, EAK
molecules bind to ODN molecules ﬁrst upon mixing, resulting in EAK-ODN complexes. The complexes further associate to form
EAK-ODNaggregates. Amethod basedonUV-Vis absorption and centrifugationwas developed to quantify the fraction ofODNs in
the aggregates. The results were used to construct binding isotherms via a binding density function analysis. To compare the
effects of different pHvaluesandnucleotide types, themodiﬁednoncooperativeMcGheeand vonHippelmodelwasused to extract
binding parameters from the binding isotherms. The binding constant of EAK to ODNs was higher at pH 4 than at pH 7, and no
bindingwas observed at pH 11, indicating that the interaction involved is primarily electrostatic in nature. EAKboundmore strongly
to single-stranded ODNs. The EAK-ODN aggregates were further visualized using atomic force microscopy; their size distribution
as a function of EAK concentrationwasmonitored by dynamic light scattering. The timescale for theEAK-ODNaggregationwas on
the order of minutes by ﬂuorescence anisotropy and steady-state light scattering experiments. Fluorescence quenching
experiments demonstrated that the ODNs in the aggregates were less accessible to the solvent, demonstrating a potential of
oligonucleotide encapsulation by the self-assembling peptide.
INTRODUCTION
Self-assembling peptides have recently emerged as one of
the most promising biomolecular materials in bio-nanotech-
nology research (1–5). The self-assembly of peptides not
only relates to many naturally occurring states of proteins,
such as amyloid ﬁbrillogenesis (4), but also provides useful
biomolecular building blocks for a wide variety of supramo-
lecular fabrications (1–3). Among the new self-assembling
peptides is a class of ionic-complementary, amphiphilic pep-
tides, e.g., EAK made of glutamic acid (E), alanine (A), and
lysine (K) residues (1). This new class of peptides originates
from zuotin, a yeast protein that preferentially binds to left-
handed Z-DNA (1). The molecular structure of these pep-
tides contains alternating positive and negative charges,
enabling ionic-complementarity. This ionic complementar-
ity, together with hydrogen-bonding, hydrophobic, and van
der Waals interactions promotes self-assembly of the peptide
molecules into highly stable aggregates (2,6,7). The nano/
microstructures constructed from the peptide self-assembly
have found many biomedical applications, including scaf-
folding for tissue engineering (8,9) and biological surface
patterning (3). It has been shown recently that these peptides
can encapsulate a hydrophobic organic compound and un-
load it into a model cell membrane in a controlled manner
(10). It is interesting to see if these self-assembling peptides
can also be used for carrying DNA or RNA in gene delivery,
which is the current bottleneck to gene therapy (11,12).
Our particular interest is the self-assembling peptide-mediated
delivery of antisense oligonucleotides and short-interfering
RNAs (siRNAs) (13).
The ﬁrst key step to develop an oligonucleotide delivery
system is to form peptide-oligonucleotide complexes (11,12).
This entails the study of the binding of the peptide to oli-
gonucleotides and the conformations of the resulting peptide-
oligonucleotide complexes. The peptide and oligonucleotides
used in this work are EAK16-II, a well-studied self-assembling
peptide (1) referred to as EAK later on, and both single- and
double-stranded oligodeoxynucleotides (ODNs), namely a
guanine hexadecamer (dG16), a cytosine hexadecamer (dC16),
and their duplex (dGC16). It has been argued that many peptide-
nucleic acid interactions are not sequence-speciﬁc, resulting
from noncovalent molecular interactions (14–23). Thus, the
dG16 and dC16 hexadecamers were chosen to assess how a
purine or a pyrimidine affects the binding of a self-assembling
peptide to an oligonucleotide. Since most therapeutic anti-
sense oligonucleotides and siRNAs are short nucleic acids of
,22 nucleotides in length, the choice of 16 mers is somewhat
arbitrary but within the usual therapeutic oligonucleotide length
range.
While there has been no study of binding between self-
assembling peptides and oligonucleotides, numerous inves-
tigations have been done on the binding between proteins
and nucleic acids (11,12,14–32). Characterization of the
binding between a ligand protein and a nucleic acid requires
the determination of the concentrations of the free and bound
species involved. These quantities can be obtained by re-
lating them to changes in the physicochemical or biological
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properties resulting from the formation of complexes (23). In
most instances, these changes can be probed by techniques
such as gel mobility shift assay (24,25), ﬁlter binding assay
(26), surface plasmon resonance (27), and ﬂuorescence (28,29).
These last methods require labeling of the ligand with a
chromophore or radioactive isotope, or covalent immobiliza-
tion of the ligand. Besides being time-consuming, labeling or
immobilization of ligands can affect their biochemical ac-
tivity, resulting in an inaccurate binding isotherm. Other
characterization methods, such as boundary sedimentation
velocity (30) and UV difference spectra (31), do not require
labeling of the molecule of interest, although labeling can be
used if the behavior of a speciﬁc species needs to be isolated
(32).
In this work, UV absorptionmeasurements were adopted in
conjunction with centrifugation of solutions of oligonucleo-
tide and peptide, where the concentration of the oligonucle-
otide left in the supernatant could be determined. This
method, also referred to as the depletion method (33), has the
advantage of not requiring large quantities of samples or any
chemical labeling. As will be shown later, this combination
of UV absorption and centrifugation may be used for a wide
range of solution systems where both molecular binding and
subsequent aggregation occur. Oligodeoxynucleotides natu-
rally exhibit a characteristic absorbance in the UV-Vis range.
Upon peptide binding, aggregates made of peptide-ODN
complexes formed. These aggregates could be centrifuged
out, leaving behind a mixture of unbound ODNs and some
EAK-ODN complexes in the supernatant. The concentration
of ODN in the supernatant was determined byUV absorption.
The experimental results were treated with a binding density
function analysis (23,34) to generate isotherms of the binding
between peptide and ODNs. The outcome was analyzed
further with the modiﬁed noncooperative McGhee and von
Hippel (MvH) model for the purpose of comparing the effects
of solution conditions and ODN types (15,22).
Some unique challenges are encountered when studying
the interaction of a self-assembling peptide with an ODN.
Since the peptide can self-assemble into nanostructures, EAK
nanoﬁbers in the present case (1,7), there is a question as to
whether EAK would bind to the ODN molecules directly, or
EAK would ﬁrst self-assemble into its aggregates to which
the ODN binds subsequently. This article presents a series of
experiments designed to demonstrate that EAK binds to
ODNs in molecular form, before the peptide self-assembly
takes place. The peptide-ODN aggregates are believed to
form after an initial step of molecular binding between pep-
tide and ODN molecules, and a subsequent association of
the peptide-ODN (intermediate) complexes into aggregates,
possibly assisted by the inherent self-assembly capability of
the peptide.
After binding and nanostructure formation with the
peptide, the ODN was further evaluated for its accessibility
to solvent species by ﬂuorescence quenching experiments, as
this property is critically important to assess the stability and
potency of ODNs during their delivery both in vitro and in vivo
(11,12). This study represents the ﬁrst example in the




All reagents were of analytical grade and obtained from BDH (Poole, UK).
The pH dependence of the binding of EAK to the ODNs was investigated by
performing experiments at three different pH values. The pH 4 buffer was
made with 0.171 M acetic acid and 0.029 M sodium acetate adjusted with
acetic acid (35); the pH 7 buffer was made with 0.01 M tris(hydroxy-
methyl)methylamine and 0.005 M sodium sulfate adjusted with sulfuric acid
(35); the pH 11 buffer was made with 0.1 M glycine and 0.1 M sodium
chloride adjusted with sodium hydroxide (36).
The EAK16-II peptidewhose sequence is shown in Table 1was purchased
from CanPeptide (Quebec, Canada) and the C-terminus carboxyﬂuorescein-
labeled EAK (FAM-EAK) were purchased from Research Genetics (Hunts-
ville, AL) and used without further puriﬁcation.
Four single-stranded oligodeoxynucleotides (ssODNs), namely dG16,
dC16, FAM-dC16 (dC16 labeled with carboxyﬂuorescein at the 59-end), and
dC16-Rh (dC16 labeled with carboxytetramethylrhodamine at the 39-end)
were obtained with 95% purity from Eurogentec North America (San Diego,
CA) with HPLC puriﬁcation. The ODN sequences are listed in Table 1.
Solutions of the double-stranded ODNs (dsODNs) at different pHs were
prepared one day before use by mixing two equimolar amounts of com-
plementary ssODNs in the corresponding buffer in Eppendorf tubes, placing
the tubes in a 95C water bath for 5 min, turning off the water bath, and
letting the solution slowly cool to room temperature.
UV-Vis absorbance
UV-Vis absorption spectra were obtained on a model No. 8452A diode array
spectrophotometer (Hewlett-Packard, Palo Alto, CA) using a 50 mL quartz
cuvette from Hellma (Mu¨llheim, Germany).
Samples for the construction of binding isotherms were prepared at pH 4,
7, and 11. For each pH, two ODN concentrations of;3 mM and 7 mMwere
used. At each ODN concentration, six-to-seven samples were prepared with
EAK concentrations ranging from 0 to 0.2 mg/mL (equivalent to 0–120 mM)
by mixing the ODN solution with different amounts of EAK powder. The
TABLE 1 Type, name, and sequence of oligonucleotides






dG16 59-GGG GGG GGG GGG GGG G-39
dC16 59-CCC CCC CCC CCC CCC C-39
FAM-dC16 59-Fluorescein-CCC CCC CCC CCC CCC C-39





dGC16 59-GGG GGG GGG GGG GGG G-39
39-CCC CCC CCC CCC CCC C-59
FAM-dGC16 59-GGG GGG GGG GGG GGG G-39
39-CCC CCC CCC CCC CCC C-Fluorescein-59
EAK16-II EAK n-AEAEAKAKAEAEAKAK-c
FAM-EAK n-AEAEAKAKAEAEAKAK-c-Fluorescein
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resulting solutions were stirred vigorously for a few seconds with a vortex
mixer and incubated at 25C for 30 min. The EAK-ODN aggregates formed
in the solution were removed by centrifugation at 14,000 rpm for 2 min with
a model No. 5410 centrifuge (Eppendorf, Hamburg, Germany). The su-
pernatant was collected and its absorbance was measured on the spectro-
photometer at wavelengths between 190 and 800 nm. Beer’s Law was used
to determine the total ODN concentration and the concentration of the ODN
left in the supernatants from the absorbance of the ODN at 260 nm of the
initial solution (ODo) and the supernatant (ODs), respectively. The term
(ODo-ODs)/ODo was deﬁned as the relative UV-Vis absorbance change
DODr. The obtained DODr were then analyzed using the ligand binding
density function (23) to generate binding isotherms.
Polyacrylamide gel electrophoresis (PAGE)
PAGE was applied to detect whether EAK-dsODN complexes/aggregates
were present in the supernatant after centrifugation. Samples containing 3.6
mM of dGC16 with 0, 0.01, 0.1, or 0.2 mg/mL (0, 6, 60, or 120 mM) of EAK
were prepared at pH 4 and 7. The supernatants obtained by centrifuging the
samples were analyzed with nondenaturing 20% PAGE. The polyacryla-
mide gels were 14-cm long 3 15-cm wide 3 0.5-mm thick. PAGE was
performed in the corresponding buffer at 10 V/cm for 2 h. The gels were
stained with a solution of 0.5 mg/mL ethidium bromide for 30 min before
being visualized with a UV Transilluminator gel document system (Bio-
Rad, Hercules, CA).
Steady-state ﬂuorescence
Fluorescence spectra of dC16 labeled with carboxyﬂuorescein at the 59-end
(FAM-dC16), dC16 labeled with carboxytetramethylrhodamine at the 39-end
(dC16-Rh), and EAK labeled with carboxyﬂuorescein at the C-terminus
(FAM-EAK) were acquired on a steady-state ﬂuorometer (Photon Technol-
ogy International, Birmingham, NJ) equipped with a Ushio UXL-75Xe
Xenon arc lamp and PTI 814 photomultiplier detection system. The peak
absorption wavelength of the solution was chosen as the excitation
wavelength (mex). For the FAM-dC16 and FAM-EAK solutions, mex was
452 nm at pH 4 and 494 nm at pH 7, respectively; for the dC16-Rh solutions,
mex was 560 nm at both pH 4 and pH 7.
Steady-state ﬂuorescence anisotropy
Anisotropy of the supernatants obtained after centrifuging the solutions was
measured using the steady-state ﬂuorometer with polarizers ﬁtted on the
excitation and emission monochromators. Each sample was excited with
vertically polarized light, and the ﬂuorescence intensity was separately
detected with the emission polarizer set in the vertical (IVV) and horizontal
(IVH) orientations. In a ﬂuorescence anisotropy experiment, the polarization
dependence of the emission monochromator was corrected by the G factor
(37). To obtain the G factor, the excitation polarizer was set to the horizontal
direction, and the ﬂuorescence intensities were measured individually with
vertical (IHV) and horizontal (IHH) emission polarization. The G factor is
given by the IHV/IHH ratio. The ﬂuorescence anisotropy (r) was calculated
using Eq. 1 (37):
r ¼ IVV  GIVH
IVV1 2GIVH
: (1)
The wavelength corresponding to the maximum absorption of FAM was
chosen as the excitation wavelength (mex). The ﬂuorescence intensity was
monitored at 514 nm, the peak wavelength of the emission spectra.
Time-resolved ﬂuorescence decays
Fluorescence decays were acquired by the time-correlated single photon
counting technique on a time-resolved ﬂuorometer (IBH System 2000,
Glasgow, UK). Samples containing 3.6 mM of the chromophore-labeled
dC16 were prepared in the presence and the absence of 0.2 mg/mL (120 mM)
EAK at pH 4. The excitation wavelength (mex) and emission wavelength
(mem) were set to the wavelength corresponding to the absorption and
emission maxima of the chromophores. For FAM-dC16, mex and mem were
452 nm and 514 nm, respectively; for dC16-Rh, mex and mem were 560 nm
and 580 nm, respectively. A right-angle conﬁguration was used between the
excitation and emission monochromators. All decay curves were collected
over 512 channels and with a total of 20,000 counts in the channel of maxi-
mum intensity. The analysis of the decay curves started by acquiring the
instrument response function obtained with a scattering solution, which was
then convoluted with a sum of exponentials shown in Eq. 2 (37)





where i ¼ 1, 2,. . . N; N is the minimum number of exponentials required to
achieve a good ﬁt. The ﬁtting parameters were optimized using the
Marquardt-Levenberg algorithm (38). The ﬁts of the ﬂuorescence decays
were deemed satisfactory when the m2 value was smaller than 1.3 and the
residuals and autocorrelation function of the residuals were randomly dis-
tributed around zero.
Steady-state light scattering (SLS)
SLS intensity of solutions of EAK, ODNs, and their mixtures was monitored
at right angle with the steady-state ﬂuorometer by irradiating the solution
at 350 nm where the ODNs and EAK do not absorb or emit.
Dynamic light scattering (DLS)
The hydrodynamic diameter of the EAK-ODN complexes/aggregates in the
pH 4 buffer was obtained with a Zetasizer Nano ZS instrument equipped
with a 4 mW He-Ne laser operating at 633 nm (Malvern Instruments,
Malvern,Worcestershire, UK). All measurements were performed at 25C at
a measurement angle of 173. Dust particles were found to be absent in the
buffer solutions used to prepare the samples, as conﬁrmed by dynamic light
scattering. DLS experiments were performed 30 min after sample prepa-
ration.
Atomic force microscopy (AFM)
A Picoscan atomic force microscope (Molecular Imaging, Tempe, AZ) was
used to study the morphology of the EAK-ODN complexes/aggregates in
solution. It was operated in magnetic AC tapping mode in solution using
magnetically coated cantilevers, Type II MAClevers (Molecular Imaging),
with a spring constant of 0.5 N/m and a resonance frequency of ;27 kHz
at room temperature. A volume of 400 mL of each solution was deposited on
a freshly cleaved mica surface, inside a Teﬂon liquid chamber, where the
AFM images were acquired.
THEORETICAL BACKGROUND
As will be shown in Results and Discussion, interaction of
EAK with ODN results in aggregates composed of EAK and
ODN. The fraction of ODNs in the aggregates can be ob-
tained from the relative change in absorbance, DODr, de-
scribed in the Experimental Section. It has been shown (39,40)
that the fraction of ODN in aggregates is a unique function of
binding density (n, which is in turn a sole function of free
ligand concentration (Pf). The binding density, n, is deﬁned as
(15,41)
Peptide-Oligonucleotide Interaction 2479
Biophysical Journal 93(7) 2477–2490
n ¼ Pb=Dt; (3)
with Pb being the concentration of the total bound peptide
and Dt the total ODN concentration expressed in terms of
phosphate groups. Thus, DODr is a unique function of Pf.
The ligand binding density function proposed by Bujalowski
and Lohman (23,34) can be adopted to construct a binding
isotherm by creating a data set (n, Pf). This procedure is
described in more detail in Section S.A of the Supplementary
Material. Brieﬂy, for any given DODr, Eq. 4 relates Pf to the
total peptide concentration and the total ODN concentration
Ptx ¼ Pf 1 nDtx; (4)
where Ptx and Dtx represent the concentrations of total
peptide and total ODN at the xth ODN concentration (there
are four ODN concentrations for each system, see Fig. 1),
respectively. Since Pf and n are constant values for a given
DODr, the binding density n can be obtained from the slope
of the plot of Pt versus Dt.
The procedure for building binding isotherms consists of
using three or four ODN concentrations and plotting the
fraction of ODN in the aggregates, i.e., DODr, as a function
of the total peptide concentration (Fig. 1). Each plot could be
ﬁtted reasonably well with the equation DODr ¼ A 3 Pt/
(11B 3 Pt), where A and B are regression parameters listed
in Table 2. In this article, sets of n and Pf were obtained from
the plot of Pt versus Dt for a given DODr. Seven-to-ten DODr
values were chosen. For each DODr value, the value of Pt
was read from the ﬁts of the curves shown in Fig. 1 and
plotted as a function ofDt. Then Pf and n were obtained from
the intercept and slope of the plot of Pt versus Dt. Plotting
n/Pf versus n generated the binding isotherms (Fig. 2). The
interaction/binding between EAK and ODN molecules most
likely starts with the formation of EAK-ODN complexes as
will be argued in Results and Discussion, which is followed
by further association of the complexes into aggregates. This





where Kc and Ka are the equilibrium constants for the for-
mation of EAK-ODN complexes from unimolecular ODN
and EAK and for the formation of EAK-ODN aggregates
from the association of EAK-ODN complexes, respectively.
One important aspect of the procedure described above is
that, although DODr represents the fraction of ODNs present
in the aggregates and does not account for the ODNs present
in the supernatant as EAK-ODN complexes, DODr is still a
unique function of Pf and n as demonstrated by the work of
Teif et al. (39,40).
No suitable theoretical model could be found in the liter-
ature to describe the molecular binding (Kc) and aggregation
(Ka) simultaneously. To do so, an isotherm would have to be
constructed for each of the two steps. To facilitate the anal-
ysis of the binding isotherms, i.e., the n/Pf versus n trends
shown in Fig. 2, the modiﬁed noncooperative McGhee and
von Hippel (MvH) model (15,22) was used:
FIGURE 1 Plots of DODr as a function of the total EAK concentration.
(A) pH 4, phosphate concentration of dG16 equals 32 mM (n), 64 mM (s),
94.4 mM (:), and 152 mM ()). (B) pH 4, phosphate concentration of dC16
equals 24 mM (n), 48 mM (s), 90 mM (:), and 116.8 mM ()). (C) pH 4,
phosphate concentration of dGC16 equals 64 mM (n), 128 mM (s), 240 mM
(:), and 288 mM ()). (D) pH 7, phosphate concentration of dG16 equals
16 mM (n), 32 mM (s), 64 mM (:), and 96 mM ()). (E) pH 7, phosphate
concentration of dC16 equals 16 mM (n), 32 mM (s), 64 mM (:), and
96 mM ()). (F) pH 7, phosphate concentration of dGC16 equals 32 mM (n),
64 mM (s), and 128 mM ()). The solid and dashed lines represent the best
ﬁts to the equation DODr¼ A3 [EAK]/(11B3 [EAK]), but do not have any
physical meaning. The A and B parameters have been listed in Table 2. Data
in the range of 20–70% of maximal DODr are used to obtain the n and n/Pf
values reported in Fig. 2.
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nPf
¼ Kð1 nnÞ 1 nn
1 ðn 1Þn
 ðn1Þ




It was noted that the MvH model describes the initial com-
plexation process only, and does not take into account the
second aggregation step. Nevertheless, we opted to use the
MvH model for the following reasons: First, the main goal of
the current study was to ﬁnd differences or similarities in the
process leading to the formation of EAK-ODN aggregates
under different experimental conditions, e.g., pH values and
nucleotide types; in other words, the MvH model is used
for comparison purpose, as has been practiced before (42).
Second, the binding constant K calculated from the MvH
model actually shows trends for the binding strength of EAK
to different ODNs and under various solution conditions,
which are also comparable with those reported for the bind-
ing of other DNA/peptide pairs. With these considerations,
the binding isotherms shown in Fig. 2 were ﬁtted with Eq. 5.
RESULTS AND DISCUSSION
This study aims at describing the interaction of EAK with
ODNs. To reach this goal, several issues were addressed by
carrying out a number of separate experiments. Each issue is
treated in a separate chapter of this section. The structure of
this section is brieﬂy laid out here. First, proof of the binding
of EAK to the ODNs was obtained by conducting absorption
measurements on the supernatant of centrifuged solutions of
the EAK-ODN mixtures. Second, PAGE, ﬂuorescence an-
isotropy, and UV-Vis absorption measurements were con-
ducted to conﬁrm that the quantity DODr is an appropriate
representation of the fraction of ODNs incorporated in the
EAK-ODN aggregates. Third, ﬂuorescence anisotropy and
steady-state light scattering experiments established that the
timescale over which the EAK-ODN aggregates form is
much shorter than that over which the self-assembly of EAK
occurs. Fourth, the size of the EAK-ODN aggregates was
determined using AFM and dynamic light scattering. Fifth,
the modiﬁedMvHmodel was used to compare the binding of
EAK to the ODNs under different pHs and nucleotide types.
Sixth, the accessibility of the ODNs to the solvent once
FIGURE 2 Plot of n/Pf versus n for the binding of EAK to dG16 (n), dC16
(s), and dGC16 (=) at (A) pH 4 and (B) pH 7. The solid lines represent the
best ﬁts to Eq. 5. The parameters used in the ﬁts are listed in Table 3.
TABLE 2 Parameters A and B retrieved from the ﬁts of the DODr versus [EAK] plots shown in Fig. 1 with the empirical equation:
DODr ¼ A 3 [EAK ]/(11B 3 [EAK ])
pH 4 dG16
Concentration 2.0 mM 4.0 mM 5.9 mM 9.5 mM
A (104) 18.454 6 3.465 4.513 6 0.507 3.574 6 0.613 2.846 6 0.248
B (104) 18.088 6 3.853 3.645 6 0.599 2.750 6 0.751 2.053 6 0.306
pH 4 dC16
Concentration 1.5 mM 3.0 mM 5.0 mM 7.3 mM
A (104) 19.262 6 2.549 9.747 6 0.981 6.954 6 1.074 5.871 6 0.583
B (104) 22.309 6 3.481 10.073 6 1.249 6.547 6 1.328 5.996 6 0.823
pH 4 dGC16
Concentration 2.0 mM 4.0 mM 7.5 mM 9.0 mM
A (104) 4.871 6 0.671 2.436 6 0.414 1.599 6 0.153 1.247 6 0.140
B (104) 5.539 6 1.048 2.440 6 0.670 1.367 6 0.254 0.878 6 0.236
pH 7 dG16
Concentration 1.0 mM 2.0 mM 4.0 mM 6.0 mM
A (104) 3.309 6 0.387 2.612 6 0.176 1.834 6 0.163 1.237 6 0.095
B (104) 3.318 6 0.587 2.425 6 0.269 1.636 6 0.267 0.844 6 0.160
pH 7 dC16
Concentration 1.0 mM 2.0 mM 4.0 mM 6.0 mM
A (104) 1.341 6 0.082 1.001 6 0.027 0.752 6 0.036 0.621 6 0.034
B (104) 1.686 6 0.175 1.035 6 0.063 0.585 6 0.085 0.339 6 0.081
pH 7 dGC16
Concentration 1.0 mM 2.0 mM 4.0 mM
A (104) 0.748 6 0.019 0.631 6 0.035 0.503 6 0.011
B (104) 0.442 6 0.038 0.306 6 0.077 0.082 6 0.023
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encapsulated inside the EAK-ODN aggregates was investi-
gated by performing ﬂuorescence quenching experiments.
Effect of pH on binding
EAK contains four glutamic acids (Glu, E) and four lysines
(Lys, K) with pKa values of 4.25 and 10.53, respectively (43).
The carboxylic acid of Glu and the amine of Lys are
negatively and positively charged at pH 7, respectively.
Therefore, EAK exhibits alternating negative and positive
charges along its backbone at pH 7. Since glutamic acid
residues are mostly protonated under acidic conditions at pHs
below 4.25, EAK molecules are expected to be positively
charged at pH 4. Similarly Lys becomes neutral at pHs above
10.53, so that EAK molecules are expected to be negatively
charged at pH 11. Since the binding of negatively charged
ODNs to cationic molecules, such as lysine-rich peptides, is
believed to be due to electrostatic attraction (44), the different
charges born by EAK at different pHs should affect the
binding of EAK to the ODNs, with a higher binding constant
being expected at lower pHs. To checkwhether this prediction
is correct, the binding of EAK to dC16, dG16, and dGC16 was
monitored at pH 4, 7, and 11. Solutions were prepared with
different EAK concentrations at two ODN concentrations.
The absorbance of the solution supernatant was measured
after the EAK-ODN aggregates had been centrifuged out.
The relative change in absorbance, DODr, was calculated by
following the procedure described in the Experimental
Section. Plots of DODr as a function of the total EAK con-
centration were generated for each ODN concentration at pH 4
and 7 (Fig. 1).
In Fig. 1, DODr is found to increase with increasing total
EAK concentration, eventually leveling off for the single-
stranded dG16 and dC16 at pH 4. This trend indicates that
more EAK binds to the ODNs upon increasing the EAK
concentration, until the ssODNs are saturated. DODr in-
creases with increasing EAK concentration at pH 7 for both
the ssODNs and the dsODN; however, it requires higher
EAK concentration to reach the plateau. Furthermore at a
given ODN concentration, the DODr values at pH 7 are
signiﬁcantly lower than those at pH 4. These results suggest
that increasing the pH from 4 to 7 results in a much weaker
binding between EAK and the ODNs. At pH 11, no binding
of EAK to the ODNs could be detected as the EAK
concentration was varied from 0 to 120 mM and DODr
equaled zero. Considering that the charge of EAK is changed
from positive to neutral, and then to negative when the pH is
increased from 4 to 7, and then to 11, the trends shown in
Fig. 1 conﬁrm the important role played by the electrostatic
forces in the binding of EAK to the ODNs.
Fig. 1 also shows the effect of the nucleotide type on
binding. The DODr values for dG16 are higher than those for
dC16 at a given EAK concentration, implying that more EAK
binds to dG16 than to dC16. The DODr values for the ssODNs
are always higher than those obtained for the dGC16 duplex
at the same EAK concentration, suggesting that EAK mole-
cules bind more strongly to the ssODNs than to the dsODN.
Nature of the ODNs remaining in the supernatant
after centrifugation
The fraction of the ODN in the EAK-ODN aggregates was
determined from the relative UV absorbance change of the
solution, DODr, by assuming that no EAK-ODN aggregates
remained in the supernatant after centrifugation. The validity
of this assumption was veriﬁed ﬁrst by ﬂuorescence aniso-
tropy experiments.
Fluorescence anisotropy reﬂects changes in the rotational
correlation time of a chromophore, which is related to the
hydrodynamic volume of the species to which the chromo-
phore is attached. Larger particles have a longer rotational
correlation time, hence a larger anisotropy (37). Solutions
containing 3.6 mM of FAM-dGC16 or of FAM-dC16 were
mixed at pH 4 and pH 7 with EAK concentrations ranging
from 0 to 0.2 mg/mL (0–120 mM). The solutions were
centrifuged and the ﬂuorescence anisotropy of the superna-
tants was measured. The anisotropy of the supernatants was
plotted in Fig. 3 as a function of EAK concentration. The
FIGURE 3 Fluorescence anisotropy of the supernatant of EAK solution
mixed with 3.6 mM of (A) FAM-dGC16 at pH 4 (lex ¼ 452 nm, lem ¼ 514
nm), (B) FAM-dGC16 at pH 7 (lex ¼ 494 nm, lem ¼ 514 nm), (C) FAM-
dC16 at pH 4 (lex ¼ 452 nm, lem ¼ 514 nm), and (D) FAM-dC16 at pH 7
(lex ¼ 494 nm, lem ¼ 514 nm).
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ﬂuorescence anisotropy of FAM-labeled ODNs equals 0.116
0.01 and 0.046 0.01 at pH 4 and pH 7, respectively. It does
not equal zero as expected for a free chromophore, because
FAM cannot rotate freely and rapidly when it is covalently
bound to ODNs. The difference in anisotropy for FAM-ODN
at pH 4 and 7 might be due to the shift of the peak absorption
wavelength of FAM-ODN from 452 to 494 nm when the pH
of the solution is raised from 4 to 7. When the FAM-labeled
ODN solution was mixed with increasing EAK concentra-
tions, the anisotropy of the FAM-labeled ODN species left in
the supernatants ranged from 0.08 to 0.12 and 0.03 to 0.04
at pH 4 and pH 7, respectively, which was very close to that
of the FAM-labeled ODN. These experiments indicate
that, within the limit of accuracy of ﬂuorescence anisotropy,
the hydrodynamic volume of the ﬂuorescently-labeled spe-
cies present in the supernatant of the EAK-ODN solutions
remains the same as that of FAM-ODN. The results dem-
onstrate that unimers of ODN existed in the centrifuged
solutions; no EAK-ODN aggregates were detected.
To estimate the resolution limit of the ﬂuorescence
anisotropy experiments, the anisotropy of a 1 mM solution
of FAM-dC16 was measured as a function of EAK concen-
tration at pH 4 and was plotted in Fig. S.B1 in the
Supplementary Material. With the K- and n-values (Table 3)
retrieved from the analysis of the binding isotherms (Fig. 2)
using Eq. 5, the fraction of ODNs incorporated in the EAK-
ODN aggregates could be calculated and is also plotted in
Fig. S.A1. It was found that;10 mol % of ODNs needs to be
present in the EAK-ODN aggregates to induce a detectable
change in ﬂuorescence anisotropy. Consequently the small
anisotropy found in Fig. 3 suggests that if EAK-ODN ag-
gregates are left in the supernatant, they account for,10 mol
% of the total ODN population. In other words, DODr shown
in Fig. 1 is an accurate representation of the fraction of ODNs
in the EAK-ODN aggregates within 610 mol %.
UV-Vis absorption experiments were performed to dem-
onstrate the existence of EAK-ODN complexes in the
supernatant that were not detected in the anisotropy exper-
iments. The absorption spectra of the samples containing 3.9
mM of dC16-Rh in the presence and absence of 60 mM EAK
were acquired before and after centrifugation. As shown in
Fig. 4, the absorption spectrum of a mixture of dC16-Rh and
EAK is different from that of free dC16-Rh. Mixing dC16-Rh
with EAK induced a decrease in the absorbance at the 563-
nm band characteristic of dC16-Rh, and a new prominent
absorption band at 524 nm. The ratio of absorbance at 524
and 563 nm (OD524/OD563) for dC16-Rh is 0.50 6 0.01 and
is concentration-independent as shown in Fig. 4 B. This ratio
changes to 0.89 and 0.78 after mixing with EAK, before and
after centrifugation, respectively. Since EAK does not
absorb where dC16-Rh does, the spectra and ratio of
OD524/OD563 for the mixtures would not be different from
that of dC16-Rh alone if there were no complexation between
EAK and dC16-Rh. The increase in the ratio of OD524/OD563
might be due to the dimer formation of rhodamine (45,46)
after EAK complexed with dC16-Rh. Since most aggregates
are centrifuged out and the ratio of OD524/OD563 after cen-
trifugation is similar to that before centrifugation, what
remains in the supernatant causing the higher OD524/OD563
ratio must be complexes, which are too small to be centrifuged
out.
Using the extinction coefﬁcients of the rhodamine dimer
reported in the literature (45), the data given in Fig. 4 A can
be analyzed to estimate the concentrations of ODNs present
in the solution as unimers (1.39 mM), complexes (1.63 mM),
and aggregates (0.88 mM). In this situation, DODr would
equal (0.88 mM)/(3.9 mM) ¼ 0.23, close to the value of 0.28
obtained from the K and n values listed in Table 3. The
agreement observed between the DODr values obtained
through two different means supports the protocol discussed
in the Theoretical Background for analyzing the UV-Vis bind-
ing results (Fig. 2).
Despite the substantial amount of complexes remaining in
the supernatant after centrifugation, no increase in anisotropy
was observed in the supernatant (Fig. 3 C), whereas the
TABLE 3 Binding constant K and binding site size n retrieved from the ﬁts of the data shown in Fig. 2 with Eq. 5
pH 4 pH 7 pH 11
ODNs n K (104 M1) n K (104 M1) N K (M1)
dG16 1.66 6 0.05 7.6 6 1.2 1.16 6 0.1 3.4 6 0.5 No interaction
dC16 1.96 6 0.02 4.7 6 0.6 1.63 6 0.03 2.0 6 0.2 No interaction
dGC16 3.16 6 0.2 4.2 6 0.8 2.6 6 0.3 0.7 6 0.02 No interaction
Each ﬁt has R2 . 0.94 with at least ﬁve data points.
FIGURE 4 UV absorption spectra of dC16-Rh in the presence and absence
of EAK at pH 7. (A) 3.9 mM dC16-Rh (d), 60 mM EAK (1), 3.9 mM dC16-
Rh and 60 mM EAK before centrifugation (—) and after centrifugation (3);
(B) dC16-Rh at concentration of 3.9 mM (d), 2.0 mM (—), and 1.3 mM (3).
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presence of aggregates in the solution results in an observ-
able increase in the anisotropy of the solution (Fig. S.A1).
These observations suggest that the aggregates are much
larger and more compact than the complexes, resulting in
reduced mobility of the ﬂuorescein label. More importantly,
they highlight the structural difference between the ﬂexible
complexes and the large, compact and rigid aggregates.
Nondenaturing PAGE experiments were further conducted
to investigate the nature of dsODN in the supernatant after
centrifugation. Samples containing 3.6 mM of dGC16 mixed
with 0, 6, 60, or 120 mM of EAK were centrifuged and their
supernatants were run on a 20% native gel at pH 4 and pH 7.
As shown in Fig. 5 A, for the gel obtained at pH 4 and stained
with ethidium bromide, the bands corresponding to the
supernatants of EAK-dGC16 mixtures (Lanes 2–4) appear at
the same position as the band corresponding to dGC16 (Lane
1). A similar observation was obtained for the gel run at pH 7
with the EAK-dGC16 mixtures (Fig. 5 B). These results
suggest that no EAK-dGC16 aggregates of a size equivalent to
6–100 basepair duplexes (47) (i.e., the basepair range of a
20% polyacrylamide gel) remain in the supernatants after
centrifugation.
The above three experiments have shown that the cen-
trifugation has separated the EAK-ODN aggregates from
the original EAK-ODN solution. In the supernatant, there
exist free EAK and ODN molecules, as well as EAK-ODN
complexes. The fact that the complexes were not detected in
either PAGE or anisotropy experiments is due to the inherent
resolution limits of the anisotropy and PAGE experiments.
Pathway of the EAK-ODN binding
Considering that EAK in solution has the potential to self-
assemble and form aggregates, two most likely pathways can
be proposed for the formation of EAK-ODN aggregates. In
Pathway 1, EAK self-assembles into aggregates onto which
the ODNs bind to form the EAK-ODN aggregates. In Path-
way 2, the self-assembly of EAK occurs on a timescale much
longer than the binding of molecular EAK onto ODNs. In
this case, the complexation of molecular EAK with ODN
molecules occurs ﬁrst, and is followed by the association of
these complexes into aggregates. To identify which pathway
is leading to the formation of EAK-ODN aggregates, the
timescale over which EAK self-assembles in solution was
estimated. To this end, the ﬂuorescence anisotropy of EAK
and EAK-dG16 mixtures was measured at pH 4 and 7 over a
1 h period immediately after sample preparation using
carboxyﬂuorescein-labeled EAK (FAM-EAK). These ex-
periments were performed with 0.1 mg/mL (60 mM) EAK
solutions where 1 in 100 EAK molecules was ﬂuorescently
labeled. To these solutions, 5 mM of dG16 was added. The
steady-state ﬂuorescence anisotropy of EAK and the EAK-
dG16 mixtures was measured at pH 4 and 7 as a function of
time. The results are shown in Fig. 6, A and B. Whether at pH
4 or 7, the ﬂuorescence anisotropy of FAM-EAK alone
remains constant as a function of time and equals 0.10 and
0.05, respectively. This trend indicates that EAK does not
self-assemble in solution within a 1 h period, at least to the
resolution limit of the anisotropy measurements. This ob-
servation is consistent with the results on the hydrodynamic
diameter of EAK measured by DLS (see below). On the
other hand, addition of dG16 to the EAK solution results in a
large increase in anisotropy, which reﬂects a large increase in
the hydrodynamic volume of the species present in solution.
These species are the EAK-ODN aggregates which may be
centrifuged out.
The interaction between individual EAK and ODN
molecules was further conﬁrmed by SLS experiments on
EAK and EAK-dG16 mixtures. The light scattered by the
EAK solution remained constant within the ﬁrst 20 min at
pH 4 and pH 7 as shown in Fig. 7, A and B, respectively. As a
control, the light scattered by dG16 in the buffer solution and
by the buffer solution alone was also monitored for 20 min.
The SLS intensity of both solutions remained constant and
close to the SLS intensity of the solution containing EAK
only. These results indicate that the size of EAK remains
FIGURE 5 20% PAGE of 3.6 mM of dGC16 mixed with EAK at (A)
pH 4 and (B) pH 7. The EAK concentrations are 0, 6, 60, 120 mM in lanes
1, 2, 3, and 4, respectively.
FIGURE 6 Fluorescence anisotropy of a 0.1 mg/mL EAK solution con-
taining 1 mol % of FAM-EAK in the presence (d) and in the absence (s) of
(A) 3.6mMof dG16 at pH 4 (lex¼ 452 nm and lem¼ 514 nm) and (B) 4.3mM
of dG16 at pH 7 (lex ¼ 494 nm and lem ¼ 514 nm).
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constant during the ﬁrst 20 min after sample preparation. In
comparison, the SLS intensity of the EAK-ODN mixtures
increased initially and then leveled off within 30 min at both
pHs. Since an increase in SLS intensity reﬂects an increase in
particle size, these results conﬁrm that the size of the
complexes/aggregates increases up to a plateau ;30 min
after mixing, a conclusion similar to that drawn from the
anisotropy experiments (Fig. 6). It is noted that the time-
scales for the formation of EAK-ODN aggregates shown in
Figs. 6 and 7 are slightly different. This is due to experi-
mental delays between the time the EAK-ODN mixture was
prepared and the measurement was conducted, which resulted
in inaccuracy for the ﬁrst 5 min. However, one can still con-
clude that the timescale for the formation of EAK-ODN aggre-
gates is much shorter than EAK self-assembly.
Size characterization of EAK-ODN aggregates by
AFM and DLS
The size of the EAK-ODN aggregates was characterized
using AFM and DLS. Images of the dG16-EAK solution
taken 8 and 60 min after sample preparation are shown in
Fig. 8. Both small ﬁbers and large aggregates were found
after 8 and 60 min and the sizes of these objects did not
change during the 1 h time period. The zoomed in view of
the image taken at 60 min shows that the smaller ﬁbers are
10-nm wide, 5.2-nm tall, and over 100-nm long. The large
aggregates appear to be giant clusters of small ﬁbers with
lateral dimensions of 650 nm and a height of 35 nm. Two
control experiments were performed: No nanostructure could
be detected when a 2 mM dG16 solution was imaged by
AFM. Sparsely distributed globular structures with a diam-
eter of 34 nm and a height of 1 nm were observed for the 0.1
mg/mL (60 mM) EAK solution 45 min after solution
preparation, which indicated that the majority of EAK
molecules do not self-assemble into ﬁbers (images shown in
Section S.C of the Supplementary Material). The small ﬁbers
and giant aggregates observed in the AFM images of the
EAK-dG16 solution are likely due to the association of the
EAK-ODN complexes into aggregates. Since the morphol-
ogies of the large aggregates observed after 8 and 60 min are
very similar, it suggests that the entire complexation process
between dG16 and EAK is complete within a short time
period, ,10 min, which agrees with the conclusions drawn
from the anisotropy (Fig. 6) and SLS (Fig. 7) results.
In addition, the hydrodynamic diameter of the EAK-ODN
aggregates in solution was obtained by DLS. The hydrody-
namic diameter of the EAK-dG16 aggregates at pH 4 with
varying concentrations of EAK was measured 30 min after
sample preparation (Fig. 9). The dG16 solutions at 7.2 mM
exhibited a species with a hydrodynamic diameter of ;7.5
nm which was attributed to isolated ODNs in solution. The
diameter of the species present in the dG16 solution increased
to;150 nm upon adding EAK and remained constant as the
EAK concentration was increased from 0.01 to 0.04 mg/mL
(6–24 mM). This result suggested that EAK binds ﬁrst to
ODN molecules, followed by aggregate formation. The
hydrodynamic diameter increased to 1000 and 2000 nm
when the EAK concentration was increased to 60 and 90
mM, respectively. This might be due to the excess EAK
binding to preformed EAK-ODN complexes, resulting in a
further increase in diameter. Under the condition used in Fig. 9,
FIGURE 7 SLS experiments performed on (s) the buffer and on sol-
utions containing (:) 3.6 mM dG16 and 0.1 mg/mL EAK; (h) 0.1 mg/mL
EAK; and (3) 3.6 mM dG16 at (A) pH 4 and (B) pH 7. lex ¼ lem ¼ 350 nm.
FIGURE 8 AFM images of the EAK-ODN complexes formed in a
solution containing 3.6 mM dG16 and 0.1 mg/mL EAK. The complexes were
imaged in solution at pH 4. (A) 8 min, (B) 60 min, (C) 70 min, and (D)
75 min. Images in panels C and D are zoomed-in views of the marked areas
in panels B and C, respectively.
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dG16 is fully incorporated in the EAK-ODN aggregates for
an EAK concentration of 60 mM, as shown in Fig. 1 (open
square, Fig. 1). Since 0.1 mg/mL (60 mM) of EAK exhibited
a size of;4 nm 40 min after preparation (Fig. 9), it indicates
that EAK does not self-assemble during that time and is
present as single molecules. The observed large diameters in
the EAK-ODN mixture solution are due to the aggregates of
ODN and EAK in solution.
The results obtained by ﬂuorescence anisotropy, SLS, and
DLS all demonstrate that neither EAKs nor the ODNs self-
assemble on their own within the ﬁrst hour or so after sample
preparation. Consequently the formation of EAK-ODN
aggregates at pH 4 and pH 7 must result from the association
of ODN and EAK unimers into complexes, which then self-
assemble into aggregates (see Scheme I).
Binding parameters
The curves shown in Fig. 1 were used to generate plots of
n/Pf as a function of n (Fig. 2). Equation 5 was used to obtain
the binding constant, K, and the binding site size, n. The
K- and n-values obtained for the binding of EAK to the ODNs
at various pH values are listed in Table 3. As discussed in
Theoretical Background, the association of the EAK-ODN
complexes into aggregates is not accounted for by the MvH
model. However the ﬁts of n/Pf versus n with the MvH
model shown in Fig. 2 are rather good.
It is observed in Fig. 1 that more EAK is required to form
the same quantity of EAK-ODN aggregates when the pH is
increased from 4 to 7, as a result of weaker electrostatic
forces at pH 7. This observation is reﬂected quantitatively in
Table 3, where the binding constant at pH 4 is 2.2-, 2.3-, and
6.0-folds larger than that at pH 7 for dG16, dC16, and dGC16,
respectively. The equilibrium constants obtained for the
binding of EAK onto the ODNs range from 7.0 3 103 to
7.6 3 104 M1. In comparison, oligolysine and lysine-rich
peptides such as KWKGK, KWK6, K4N4, K4N6, and Kn
(n ¼ 3–8) have been reported to bind to oligo- and
polynucleotides with binding constants in the range of
1 3 103 ; 1 3 105 M1 (18,41,48,49). These values are
comparable to those listed in Table 3.
The base composition of the ODN sequences, guanine in
dG16 and cytosine in dC16, appears to affect the binding of
EAK to the ODNs since EAK binds more strongly to dG16
than to dC16 at both pH 4 and 7 (Table 3). Statistical analysis
of protein-DNA complexes has established that Lys binds
more readily to guanine (G) than to cytosine (C) (50).
Binding of Lys to G occurs more effectively via hydrogen
bonds to the two acceptors of the G base, whereas Lys binds
preferentially to the phosphate oxygens of the C nucleotide.
Furthermore, the study found that Lys has the highest
propensity to interact with nucleotides, whereas Glu and Ala
have the lowest (50). Since the interactions between nucleo-
tides and glutamic acid are poor and since the favorable
electrostatic forces between the negatively charged backbone
of the ODNs and EAK are expected to be similar for dG16
and dC16, the observation that dG16 binds more strongly
to EAK than dC16 is rationalized by the enhanced formation
of hydrogen bonds between the lysines of EAK and the
guanines of dG16.
The data listed in Table 3 indicate that EAK binds
preferentially to ssODNs rather than to their duplex. This
phenomenon has been observed for other peptides (12). This
might be caused by the formation of hydrogen bonds be-
tween the amino acids of EAK and the nucleotide bases of
ssODNs. This favorable interaction disappears in the case of
dsODNs, since each nucleotide base hydrogen-bonds with
the opposite base in the complementary strand of the duplex.
Solvent accessibility of ODNs in the
EAK-ODN aggregates
One important aspect of the structure of the EAK-ODN
aggregates is whether the ODNs are located inside or outside
the aggregates. ODNs located inside the aggregates will be
less accessible to the solvent than those located on the
surface, and hence be protected from the outside environ-
ment. The accessibility of the ODN to the solvent was
measured by performing ﬂuorescence dynamic quenching
experiments. dC16 was labeled either at the 59-end with
ﬂuorescein (FAM-dC16, lex ¼ 452 nm, lem ¼ 514 nm) or at
the 39-end with rhodamine (dC16-Rh, lex ¼ 560 nm, lem ¼
580 nm) to investigate whether both ends of dC16 are
protected from the solvent. The ﬂuorescence emission of a
solution containing 3.6 mM of the labeled dC16 was moni-
tored as the quencher KI was added to the solution in the
presence or absence of 0.2 mg/mL EAK. Throughout these
experiments, the potassium ion concentration was main-
tained constant and equal to 0.3 M by addition of K2SO4 to
the KI solution, ensuring constant ionic strength.
FIGURE 9 Population histogram of the EAK-ODN complexes as a
function of particle diameter determined by dynamic light scattering. The
EAK-ODN solutions contained 7.2 mM of dG16 with increasing EAK
concentration at pH 4. The sample of EAK alone was measured 40 min after
preparation, whose concentration was 0.1 mg/mL (60 mM). The concen-
tration of dG16 alone was 7.2 mM.
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As the KI concentration increased, the ﬂuorescence
intensity of ﬂuorescein or rhodamine decreased. The Io/I
ratio was plotted as a function of iodide concentration in
Fig. 10, A and B, for ﬂuorescein and rhodamine, respectively.
The quantities Io and I represent the ﬂuorescence intensity of
the chromophore without and with quencher, respectively. The
Io/I ratio was found to increase linearly with iodide con-
centration for both chromophores in the absence or presence
of EAK. However, the increase was stronger in the absence
of EAK.
The ﬂuorescence decays of FAM-dC16 and dC16-Rh were
acquired in the presence and absence of EAK. They were
ﬁtted with two exponentials according to Eq. 2. The
preexponential factors and decay times obtained from the
ﬁts are listed in Table 4. Although ﬂuorescein itself displays
a single lifetime of 4.1 ns (51), the decay becomes more
complex when ﬂuorescein is covalently attached to an ODN
where it shows two decay times. This phenomenon has been
reported (52) to be due to a change in the conformation of
ﬂuorescein when it is covalently linked to an ODN. The bind-
ing of EAK onto the labeled ODN does not change the lifetime
of the chromophore signiﬁcantly as shown in Table 4.
To ensure that the quenching is dynamic, the ﬂuorescence
decays of the FAM-dC16-EAK mixture were acquired in the
absence and presence of 0.2 M KI. The average lifetime of
the decays was determined and the ratio of the average
lifetime of the solution without KI (to) over that of the
solution with 0.2 M KI (t) was found to be 1.8, i.e.,
to/t ¼1.8. The Io/I ratio obtained from the steady-state
ﬂuorescence measurements equaled 1.9 for a concentration
of 0.2 M KI, a value comparable to the to/t ratio. The
agreement obtained between the Io/I and to/t ratios strongly
suggests that the quenching is dynamic (37). Fitting the Io/I
versus [I] trends shown in Fig. 10 with the Stern-Volmer
equation given in Eq. 6 yields the bimolecular quenching rate
constant, kq, which reﬂects the accessibility of the chromo-
phore to the solvent (37),
Io=I ¼ 11KSV½Q ¼ 11 kqto½Q: (6)
The slopes of the straight lines referred to as the Stern-
Volmer constants, KSV, are listed in Table 5. As indicated in
Eq. 6, kq is determined from the ratio KSV/to where to is the
lifetime of the chromophore in the absence of quencher (37).
Since the ﬂuorescence decay of the chromophores without
quencher is biexponential, the average lifetime to was used
to calculate the bimolecular quenching rate constant kq from
the slope KSV of the plots in Fig. 10. The values of KSV, to;
and kq are listed in Table 5. In the absence of EAK, kq
for FAM-dC16 and dC16-Rh equals 2.5 3 10
9 M1 s1 and
3.53 109 M1 s1, respectively. The bimolecular quenching
rate constant is related to the quenching efﬁciency, size, and
diffusion coefﬁcient of the chromophore and quencher. Since
the iodide ions have quenching efﬁciencies near unity (37)
and the overall sizes of the two labeled ODNs are com-
parable, the differences in kq found for FAM-dC16 and
dC16-Rh (Table 5) must reﬂect differences in the efﬁciency
of iodide at quenching the excited chromophores. Indeed,
FAM and Rh are neutral and positively charged at pH 4,
respectively. Considering electrostatic forces alone, the neg-
atively charged iodide ions are expected to quench more
efﬁciently to Rh than FAM. In addition, FAM is expected to
be less mobile than Rh as an 8- and 12-atom linker connects
the 59-end and the 39-end phosphate groups of dC16 to FAM
and Rh, respectively. In the presence of EAK, kq decreases
for both FAM-dC16 and dC16-Rh. For FAM-dC16, kq de-
creases from 2.5 3 109 M1 s1 to 1.5 3 109 M1 s1.
Similarly, for dC16-Rh, kq decreases from 3.53 10
9 M1 s1
to 2.0 3 109 M1 s1. Considering the diffusion coefﬁcient
of the ﬂuorophore-labeled ODN of 16 bases would be ;1.3
3 106 cm2/s (53), which is 10-fold lower than that of iodide
ion with 1.9 3 105 cm2/s (54), kq will be affected at most
10% by the diminution of the diffusion coefﬁcient of the
ODNs after incorporation in the EAK-ODN aggregates.
FIGURE 10 Stern-Volmer plots for a solution of 3.6 mM of ﬂuorescently-
labeled dC16 free and bound to 0.2 mg/mL of EAK at pH 4 quenched by KI.
Solid lines represent the ﬁts to the Stern-Volmer equation with param-
eters listed in Table 5. (A) FAM-dC16 (:), FAM-dC16-EAK (h); and (B)
dC16-Rh (:), and dC16-Rh-EAK (h).
TABLE 4 Preexponential factors and decay times obtained from the analysis of the ﬂuorescence decays of the ﬂuorescent ODNs in
the absence and presence of EAK in pH 4 buffer, respectively
t1 (ns) a1 t2 (ns) a2 t (ns)* x
2
FAM-dC16 (without KI) 3.9 0.67 2.0 0.33 3.3 1.12
EAK-FAM-dC16 (without KI) 3.7 0.63 1.7 0.37 3.0 1.00
EAK-FAM-dC16 (with KI) 2.8 0.43 1.0 0.57 1.7 1.15
dC16-Rh (without KI) 3.9 0.60 1.5 0.40 2.9 1.13
EAK-dC16-Rh(without KI) 3.8 0.58 1.3 0.42 2.8 1.37
*t is the number average lifetime, given by t ¼ +tiai=+ai.
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Thus, the decrease in kq observed in Table 5 (;40%) sug-
gests that the accessibility of ODNs must be reduced after
binding to EAK.
The change in accessibility of the ODNs upon EAK
binding was quantiﬁed with the relative accessibility change,
g, deﬁned by (34)
g ¼ kbq=kfq; (7)
where kbq and k
f
q are the bimolecular quenching constants for
the chromophore-labeled ODNs in the presence and absence
of EAK, respectively. The values of g for the two different
labels are listed in Table 5. The relative accessibility changes
of dC16 for both types of labels are similar and smaller than
unity, being 0.60 and 0.57 for the 59-labeled FAM-dC16 and
the 39-labeled dC16-Rh, respectively. Since g is smaller than
1.0, the accessibility of the 59- and 39-ends of dC16 to the
solvent is reduced after the binding of EAK to dC16. Since
the g-values corresponding to the two labels are similar, the
accessibility of both ends of dC16 to the solvent is reduced by
the same extent,;40%. The fact that different sections of the
ODN exhibit a similar reduction in accessibility suggests that
the entire ODN molecule is protected by the EAK molecules
inside the EAK-ODN aggregates.
It is worth noting that while the negatively charged ODNs
should repel the quencher (I), the negative charges on the
ODNs are, at least partially, neutralized by the positively
charged EAK in the EAK-ODN aggregates. Consequently
the iodide ions would be expected to be more efﬁcient at
colliding with the ODNs in the presence of EAK. Interest-
ingly the opposite is observed, which strengthens the claim
that EAK protects the ODN from its environment.
Unprotected ODNs are rapidly degraded in vitro and in
vivo due to the presence of nucleases. The reduction of ac-
cessibility to the solvent experienced by the ODNs upon
assembly with EAK suggests that the degradation of the
complexed ODN will be reduced when used in biological
systems. Further investigations are underway to verify the
stability of the EAK-ODN aggregates and the potential of
ODN encapsulation by EAK for oligonucleotide delivery.
CONCLUSIONS
In this work the molecular interaction of EAK with ODNs in
solution was studied by a number of physicochemical meth-
ods. UV-Vis absorption experiments showed that the bind-
ing between EAK and ODNs resulted in the formation of
EAK-ODN aggregates that could be centrifuged out. Fluo-
rescence anisotropy, PAGE, and UV-Vis experiments dem-
onstrated that EAK-ODN complexes, as well as EAK and
ODN unimers, existed in the supernatant of the centrifuged
EAK-ODN mixtures. The binding isotherms between EAK
and ODNs were established from the UV-Vis absorption re-
sults through a binding density function analysis. Fluorescence
anisotropy and static light scattering experiments showed
that the process of EAK binding to ODNs started with EAK-
ODN molecular complexation, followed by association of
the complexes into aggregates. For comparison purposes, the
binding isotherm was ﬁtted with the modiﬁed noncoopera-
tive MvH model to extract the equilibrium binding constants.
The binding was found to be strongest at pH 4. No binding
was observed at pH 11. The equilibrium binding constant
decreases two-to-sixfold when the pH changes from 4 to 7.
Since the equilibrium binding constant decreases as EAK be-
comes less positively charged, the interaction between EAK
and ODNs must occur mainly via electrostatic interactions,
but hydrogen bonding between EAK and the nucleotides of
the ODNs may also be involved. Hydrogen bonds are be-
lieved to promote the binding of EAK to dG16 to a greater ex-
tent than to dC16. Furthermore, EAK has a slight preference
to bind with the ssODNs than to the dsODN.
The size of EAK-ODN aggregates was determined by AFM
and DLS, and found to equal ;150 nm at low EAK con-
centrations. Fluorescence quenching experiments showed that
the accessibility of ODNs to the solvent was reduced upon
EAK binding. EAK-ODN aggregates can protect the ODNs
from encountering the quencher in the surrounding solvent.
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